The Experts below are selected from a list of 191103 Experts worldwide ranked by ideXlab platform
Hansjurgen Moller - One of the best experts on this subject based on the ideXlab platform.
-
guidelines for the Pharmacological Treatment of anxiety disorders obsessive compulsive disorder and posttraumatic stress disorder in primary care
International Journal of Psychiatry in Clinical Practice, 2012Co-Authors: Borwin Bandelow, Joseph Zohar, Siegfried Kasper, Hansjurgen Moller, Eric Hollander, Leo Sher, Robertas Bunevicius, Ocd Wfsbp Task Force On Anxiety DisordersAbstract:Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners. Methods. This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the Pharmacological Treatment of anxiety disorders, obsessive – compulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the Treatment in primary care. The recommendations were developed by a task force of 30 international experts in the fi eld and are based on randomized controlled studies. Results. First-line Pharmacological Treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired Treatment strategy. Conclusions. This short version of an evidence-based guideline may improve Treatment of anxiety disorders, OCD, and PTSD in primary care.
-
world federation of societies of biological psychiatry wfsbp guidelines for the Pharmacological Treatment of anxiety obsessive compulsive and post traumatic stress disorders first revision
World Journal of Biological Psychiatry, 2002Co-Authors: Borwin Bandelow, Joseph Zohar, Siegfried Kasper, Eric Hollander, Hansjurgen MollerAbstract:In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002, World J Biol Psychiatry 3:171), recommendations for the Pharmacological Treatment of anxiety disorder, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are presented. Since the publication of the first version of this guideline, a substantial number of new randomized controlled studies of anxiolytics have been published. In particular, more relapse prevention studies are now available that show sustained efficacy of anxiolytic drugs. The recommendations, developed by the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-traumatic Stress Disorders, a consensus panel of 30 international experts, are now based on 510 published randomized, placebo- or comparator-controlled clinical studies (RCTs) and 130 open studies and case reports. First-line Treatments for these disorders are selective ser...
Borwin Bandelow - One of the best experts on this subject based on the ideXlab platform.
-
guidelines for the Pharmacological Treatment of anxiety disorders obsessive compulsive disorder and posttraumatic stress disorder in primary care
International Journal of Psychiatry in Clinical Practice, 2012Co-Authors: Borwin Bandelow, Joseph Zohar, Siegfried Kasper, Hansjurgen Moller, Eric Hollander, Leo Sher, Robertas Bunevicius, Ocd Wfsbp Task Force On Anxiety DisordersAbstract:Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners. Methods. This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the Pharmacological Treatment of anxiety disorders, obsessive – compulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the Treatment in primary care. The recommendations were developed by a task force of 30 international experts in the fi eld and are based on randomized controlled studies. Results. First-line Pharmacological Treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired Treatment strategy. Conclusions. This short version of an evidence-based guideline may improve Treatment of anxiety disorders, OCD, and PTSD in primary care.
-
world federation of societies of biological psychiatry wfsbp guidelines for the Pharmacological Treatment of anxiety obsessive compulsive and post traumatic stress disorders first revision
World Journal of Biological Psychiatry, 2002Co-Authors: Borwin Bandelow, Joseph Zohar, Siegfried Kasper, Eric Hollander, Hansjurgen MollerAbstract:In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002, World J Biol Psychiatry 3:171), recommendations for the Pharmacological Treatment of anxiety disorder, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are presented. Since the publication of the first version of this guideline, a substantial number of new randomized controlled studies of anxiolytics have been published. In particular, more relapse prevention studies are now available that show sustained efficacy of anxiolytic drugs. The recommendations, developed by the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-traumatic Stress Disorders, a consensus panel of 30 international experts, are now based on 510 published randomized, placebo- or comparator-controlled clinical studies (RCTs) and 130 open studies and case reports. First-line Treatments for these disorders are selective ser...
Siegfried Kasper - One of the best experts on this subject based on the ideXlab platform.
-
guidelines for the Pharmacological Treatment of anxiety disorders obsessive compulsive disorder and posttraumatic stress disorder in primary care
International Journal of Psychiatry in Clinical Practice, 2012Co-Authors: Borwin Bandelow, Joseph Zohar, Siegfried Kasper, Hansjurgen Moller, Eric Hollander, Leo Sher, Robertas Bunevicius, Ocd Wfsbp Task Force On Anxiety DisordersAbstract:Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners. Methods. This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the Pharmacological Treatment of anxiety disorders, obsessive – compulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the Treatment in primary care. The recommendations were developed by a task force of 30 international experts in the fi eld and are based on randomized controlled studies. Results. First-line Pharmacological Treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired Treatment strategy. Conclusions. This short version of an evidence-based guideline may improve Treatment of anxiety disorders, OCD, and PTSD in primary care.
-
world federation of societies of biological psychiatry wfsbp guidelines for the Pharmacological Treatment of eating disorders
World Journal of Biological Psychiatry, 2011Co-Authors: Martin Aigner, Janet Treasure, Walter H Kaye, Siegfried KasperAbstract:AbstractObjectives. The Treatment of eating disorders is a complex process that relies not only on the use of psychotropic drugs but should include also nutritional counselling, psychotherapy and the Treatment of the medical complications, where they are present. In this review recommendations for the Pharmacological Treatment of eating disorders (anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED)) are presented, based on the available literature. Methods. The guidelines for the Pharmacological Treatment of eating disorders are based on studies published between 1977 and 2010. A search of the literature included: anorexia nervosa bulimia nervosa, eating disorder and binge eating disorder. Many compounds have been studied in the therapy of eating disorders (AN: antidepressants (TCA, SSRIs), antipsychotics, antihistaminics, prokinetic agents, zinc, Lithium, naltrexone, human growth hormone, cannabis, clonidine and tube feeding; BN: antidepressants (TCA, SSRIs, RIMA, NRI, other AD), ant...
-
world federation of societies of biological psychiatry wfsbp guidelines for the Pharmacological Treatment of anxiety obsessive compulsive and post traumatic stress disorders first revision
World Journal of Biological Psychiatry, 2002Co-Authors: Borwin Bandelow, Joseph Zohar, Siegfried Kasper, Eric Hollander, Hansjurgen MollerAbstract:In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002, World J Biol Psychiatry 3:171), recommendations for the Pharmacological Treatment of anxiety disorder, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are presented. Since the publication of the first version of this guideline, a substantial number of new randomized controlled studies of anxiolytics have been published. In particular, more relapse prevention studies are now available that show sustained efficacy of anxiolytic drugs. The recommendations, developed by the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-traumatic Stress Disorders, a consensus panel of 30 international experts, are now based on 510 published randomized, placebo- or comparator-controlled clinical studies (RCTs) and 130 open studies and case reports. First-line Treatments for these disorders are selective ser...
Eric Hollander - One of the best experts on this subject based on the ideXlab platform.
-
guidelines for the Pharmacological Treatment of anxiety disorders obsessive compulsive disorder and posttraumatic stress disorder in primary care
International Journal of Psychiatry in Clinical Practice, 2012Co-Authors: Borwin Bandelow, Joseph Zohar, Siegfried Kasper, Hansjurgen Moller, Eric Hollander, Leo Sher, Robertas Bunevicius, Ocd Wfsbp Task Force On Anxiety DisordersAbstract:Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners. Methods. This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the Pharmacological Treatment of anxiety disorders, obsessive – compulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the Treatment in primary care. The recommendations were developed by a task force of 30 international experts in the fi eld and are based on randomized controlled studies. Results. First-line Pharmacological Treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired Treatment strategy. Conclusions. This short version of an evidence-based guideline may improve Treatment of anxiety disorders, OCD, and PTSD in primary care.
-
world federation of societies of biological psychiatry wfsbp guidelines for the Pharmacological Treatment of anxiety obsessive compulsive and post traumatic stress disorders first revision
World Journal of Biological Psychiatry, 2002Co-Authors: Borwin Bandelow, Joseph Zohar, Siegfried Kasper, Eric Hollander, Hansjurgen MollerAbstract:In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002, World J Biol Psychiatry 3:171), recommendations for the Pharmacological Treatment of anxiety disorder, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are presented. Since the publication of the first version of this guideline, a substantial number of new randomized controlled studies of anxiolytics have been published. In particular, more relapse prevention studies are now available that show sustained efficacy of anxiolytic drugs. The recommendations, developed by the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-traumatic Stress Disorders, a consensus panel of 30 international experts, are now based on 510 published randomized, placebo- or comparator-controlled clinical studies (RCTs) and 130 open studies and case reports. First-line Treatments for these disorders are selective ser...
Joseph Zohar - One of the best experts on this subject based on the ideXlab platform.
-
guidelines for the Pharmacological Treatment of anxiety disorders obsessive compulsive disorder and posttraumatic stress disorder in primary care
International Journal of Psychiatry in Clinical Practice, 2012Co-Authors: Borwin Bandelow, Joseph Zohar, Siegfried Kasper, Hansjurgen Moller, Eric Hollander, Leo Sher, Robertas Bunevicius, Ocd Wfsbp Task Force On Anxiety DisordersAbstract:Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners. Methods. This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the Pharmacological Treatment of anxiety disorders, obsessive – compulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the Treatment in primary care. The recommendations were developed by a task force of 30 international experts in the fi eld and are based on randomized controlled studies. Results. First-line Pharmacological Treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired Treatment strategy. Conclusions. This short version of an evidence-based guideline may improve Treatment of anxiety disorders, OCD, and PTSD in primary care.
-
world federation of societies of biological psychiatry wfsbp guidelines for the Pharmacological Treatment of anxiety obsessive compulsive and post traumatic stress disorders first revision
World Journal of Biological Psychiatry, 2002Co-Authors: Borwin Bandelow, Joseph Zohar, Siegfried Kasper, Eric Hollander, Hansjurgen MollerAbstract:In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002, World J Biol Psychiatry 3:171), recommendations for the Pharmacological Treatment of anxiety disorder, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are presented. Since the publication of the first version of this guideline, a substantial number of new randomized controlled studies of anxiolytics have been published. In particular, more relapse prevention studies are now available that show sustained efficacy of anxiolytic drugs. The recommendations, developed by the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-traumatic Stress Disorders, a consensus panel of 30 international experts, are now based on 510 published randomized, placebo- or comparator-controlled clinical studies (RCTs) and 130 open studies and case reports. First-line Treatments for these disorders are selective ser...
